AQST Operating Expenses

Aquestive Therapeutics Inc · Operating Expenses

AQST logo

AQST Operating Expenses

Latest reported$89.00M
AQST Operating Expenses ($36.25M → $89.00M)
High-resolution chart · PNG

AQST operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
97,041,000
70,460,000
44,854,000
70,360,000
70,522,000
75,778,000
84,916,000
95,376,000
47,211,000
36,254,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.